Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Supplementary material For supplementary material accompanying this paper visit Acknowledgements The authors would like to thank the Clinical Research Development Unit of Baqiyatallah Hospital, for all their support and guidance during carrying out this study
A.KarayiorgouM
Glucagon-like peptide-1 receptor agonists and hepatocellular carcinoma prevention: a meta-analysis and clinical decision framework
A patient with favorable GLP1R or GIPR variants may theoretically benefit more from GLP-1 therapy, while results should always be discussed with a qualified healthcare provider in the context of your complete health profile
Discover More Products to Support Your Health & Well-Being Explore More Products
US$ 21.93
US$ 26.95
US$ 26.73
